Published • loading... • Updated
NHS pilots rapid genomic test to transform brain tumour diagnosis and treatment, experts say
The nanopore test identifies tumour type in about two hours, helping patients start treatment sooner and reach clinical trials faster, NHS England said.
- NHS England launched a pioneering rapid genomic test that slashes brain tumour diagnosis times from up to eight weeks to two hours, enabling faster treatment and clinical trial access.
- Brain tumours remain "notoriously difficult" to identify, with over 100 distinct forms existing; more than 12,000 people in the UK are diagnosed annually, facing weeks of agonizing uncertainty.
- Using shoebox-sized Oxford Nanopore sequencers, clinicians analyze tumour samples in 20 minutes; Neurosurgeon Stuart Smith at Nottingham University Hospitals NHS Trust recently used this method to diagnose patient Steve Palmer during surgery.
- Prof Frankie Swords, NHS medical director, said the test "has the potential to completely transform" diagnosis and care, enabling faster access to tailored treatments and clinical trials.
- The pilot involves five specialist centres in Nottingham, Birmingham, London, and Newcastle, with expansion plans to Bristol, Oxford, Leeds, and Manchester, ensuring consistent national access.
Insights by Ground AI
7 Articles
7 Articles
Brain tumour patients are to be offered rapid genetic testing as part of a new pilot study which experts say could "transform" diagnosis and treatment.
The IndependentReposted by 
The Independent (US)
The Independent (US)Hopes for thousands after breakthrough in brain tumour treatment
The breakthrough is expected to reduce diagnosis times from weeks to days
·London, United Kingdom
Read Full ArticleCoverage Details
Total News Sources7
Leaning Left2Leaning Right1Center3Last UpdatedBias Distribution50% Center
Bias Distribution
- 50% of the sources are Center
50% Center
L 33%
C 50%
R 17%
Factuality
To view factuality data please Upgrade to Premium
